Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Feb 15;266(1):127–132. doi: 10.1042/bj2660127

Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.

J E Souness 1, B K Diocee 1, W Martin 1, S A Moodie 1
PMCID: PMC1131105  PMID: 2155604

Abstract

Two cyclic nucleotide phosphodiesterase (PDE) activities were identified in pig aortic endothelial cells, a cyclic GMP-stimulated PDE and a cyclic AMP PDE. Cyclic GMP-stimulated PDE had Km values of 367 microM for cyclic AMP and 24 microM for cyclic GMP, and low concentrations (1 microM) of cyclic GMP increased the affinity of the enzyme for cyclic AMP (Km = 13 microM) without changing the Vmax. This isoenzyme was inhibited by trequinsin [IC50 (concn. giving 50% inhibition of substrate hydrolysis) = 0.6 microM for cyclic AMP hydrolysis in the presence of cyclic GMP; IC50 = 0.6 microM for cyclic GMP hydrolysis] and dipyridamole (IC50 = 5 microM for cyclic AMP hydrolysis in the presence of cyclic GMP; IC50 = 3 microM for cyclic GMP hydrolysis). Cyclic AMP PDE exhibited a Km of 2 microM for cyclic AMP and did not hydrolyse cyclic GMP. This activity was inhibited by trequinsin (IC50 = 0.2 microM), dipyridamole (IC50 = 6 microM) and, selectively, by rolipram (IC50 = 3 microM). Inhibitors of cyclic GMP PDE (M&B 22948) and of low Km (Type III) cyclic AMP PDE (SK&F 94120) only weakly inhibited the two endothelial PDEs. Incubation of intact cells with trequinsin and dipyridamole induced large increases in cyclic GMP, which were completely blocked by LY-83583. Rolipram, SK&F 94120 and M&B 22948 did not significantly influence cyclic GMP accumulation. Dipyridamole enhanced the increase in cyclic GMP induced by sodium nitroprusside. Cyclic AMP accumulation was stimulated by dipyridamole and trequinsin with and without forskolin. Rolipram, although without effect alone, increased cyclic AMP in the presence of forskolin, whereas M&B 22948 and SK&F 94120 had no effects on resting or forskolin-stimulated levels. These results suggest that cyclic GMP-stimulated PDE regulates cyclic GMP levels and that both endothelial PDE isoenzymes contribute to the control of cyclic AMP.

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crossman D., McEwan J., MacDermot J., MacIntyre I., Dollery C. T. Human calcitonin gene-related peptide activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cells. Br J Pharmacol. 1987 Dec;92(4):695–701. doi: 10.1111/j.1476-5381.1987.tb11373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dembinska-Kiec A., Rücker W., Schönhöfer P. S. Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries. Naunyn Schmiedebergs Arch Pharmacol. 1980 Feb;311(1):67–70. doi: 10.1007/BF00500304. [DOI] [PubMed] [Google Scholar]
  4. Doni M. G., Whittle B. J., Palmer R. M., Moncada S. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol. 1988 Jun 22;151(1):19–25. doi: 10.1016/0014-2999(88)90687-5. [DOI] [PubMed] [Google Scholar]
  5. Federation of American Societies for Experimental Biology. 72nd annual meeting. Las Vegas, Nevada, May 1-5, 1988. Abstracts of papers 1-3785. FASEB J. 1988 Mar 15;2(4):A297–A946. [PubMed] [Google Scholar]
  6. Goldman S. J., Dickinson E. S., Slakey L. L. Effect of adenosine on synthesis and release of cyclic AMP by cultured vascular cells from swine. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(1):69–78. [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Lee M. A., West R. E., Jr, Moss J. Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity. J Clin Invest. 1988 Aug;82(2):388–393. doi: 10.1172/JCI113610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lugnier C., Schoeffter P., Le Bec A., Strouthou E., Stoclet J. C. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol. 1986 May 15;35(10):1743–1751. doi: 10.1016/0006-2952(86)90333-3. [DOI] [PubMed] [Google Scholar]
  10. Makarski J. S. Stimulation of cyclic AMP production by vasoactive agents in cultured bovine aortic and pulmonary artery endothelial cells. In Vitro. 1981 May;17(5):450–458. doi: 10.1007/BF02626746. [DOI] [PubMed] [Google Scholar]
  11. Martin W., Villani G. M., Jothianandan D., Furchgott R. F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985 Mar;232(3):708–716. [PubMed] [Google Scholar]
  12. Martin W., White D. G., Henderson A. H. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol. 1988 Jan;93(1):229–239. doi: 10.1111/j.1476-5381.1988.tb11426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mizuno-Yagyu Y., Hashida R., Mineo C., Ikegami S., Ohkuma S., Takano T. Effect of PGI2 on transcellular transport of fluorescein dextran through an arterial endothelial monolayer. Biochem Pharmacol. 1987 Nov 15;36(22):3809–3813. doi: 10.1016/0006-2952(87)90442-4. [DOI] [PubMed] [Google Scholar]
  14. Mülsch A., Busse R., Liebau S., Förstermann U. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther. 1988 Oct;247(1):283–288. [PubMed] [Google Scholar]
  15. Reeves M. L., Leigh B. K., England P. J. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem J. 1987 Jan 15;241(2):535–541. doi: 10.1042/bj2410535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shimokawa H., Flavahan N. A., Lorenz R. R., Vanhoutte P. M. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br J Pharmacol. 1988 Dec;95(4):1197–1203. doi: 10.1111/j.1476-5381.1988.tb11756.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sterzel W., Bedford P., Eisenbrand G. Automated determination of DNA using the fluorochrome Hoechst 33258. Anal Biochem. 1985 Jun;147(2):462–467. doi: 10.1016/0003-2697(85)90299-4. [DOI] [PubMed] [Google Scholar]
  18. Thompson W. J., Terasaki W. L., Epstein P. M., Strada S. J. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucleotide Res. 1979;10:69–92. [PubMed] [Google Scholar]
  19. Torphy T. J. Action of mediators on airway smooth muscle: functional antagonism as a mechanism for bronchodilator drugs. Agents Actions Suppl. 1988;23:37–53. doi: 10.1007/978-3-0348-9156-1_2. [DOI] [PubMed] [Google Scholar]
  20. Voyta J. C., Via D. P., Butterfield C. E., Zetter B. R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 1984 Dec;99(6):2034–2040. doi: 10.1083/jcb.99.6.2034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Waldman S. A., Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987 Sep;39(3):163–196. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES